Ağır Obstrüktif Uyku Apne Sendromlu Hastalarda Ortalama Trombosit Hacminin Değerlendirilmesi
Amaç: Bu çalışmada ağır tıkayıcı uyku apne sendromlu (OSAS) hastalarda kan koagülabilitesiyle ilişkili
Ortalama Trombosit Hacmini (MPV) ve Plateletcriti (PCT) değerlendirmeyi amaçladık.
Gereç ve yöntemler: Uyku ünitesinde Eylül 2013 öncesi polisomnografi yapılan 98 hastanın kayıtları
retrospektif değerlendirildi. Tüm olgular apne-hipopne indeksine(AHİ) göre AHİ <5 / saat (s=48) AGrubu
(kontrol), AHİ ≥ 30 / saat ile B Grubu (s = 50) şeklinde gruplandırıldı. MPVve PCT(plateletcrit) otomatik bir
kan hücresi sayacı kullanılarak ölçüldü. Polisomnografik bulgularla, demografik ve kan parametreleri
karşılaştırıldı.
Bulgular: A ve B grupları arasında MPV (7.17±0.98 karşılık 7.54±1.21fL, p=0.66) ve PCT (0.218±0.06
karşılık 0.212±0.05, p=0.66) açısından anlamlı farklılık bulunamadı. Ağır OSAS grubunda MPV, PCT ile
AHİ parametreleri arasında anlamlı korelasyon saptanmadı(r=0.37, p=0.801 ve r=0.61, p=0.624).
Sonuç: MPV ve PCT değerlerinde ağır OSAS'lı hastalarda kontrole göre anlamlı yükseklik bulunmadı.Bu
bulgular yapılan ilk çalışmaların aksine MPV'nin OSAS'ın ağırlığıyla ilişkili bir parametre olmadığı ve
OSAS'ın doğrudan trombosit aktivitesini etkilemediğini düşündürmektedir.
Assessment Of Mean Platelet Volume In Patients With Severe Obstructive Sleep Apnea
Objective: In this study we aimed to evaluate the mean platelet volume (MPV) and Plateletcrit (PCT)
associated with blood coagulability in patients with severe obstructive sleep apnea syndrome (OSAS).
Materials And Methods: The polysomnography recordings of 98 patients admitted to the sleep laboratory
before September 2013 were retrospectively evaluated. All cases were grouped according to their AHI value
as AHI <5 / h (n = 48) Group A (control) and AHI ≥ 30 / hour and Group B (n = 50). MPV and PCT
(plateletcrit) was measured using an automatic blood cell counter. Polysomnographic findings, demographic
data and blood parameters were compared. Results: No significant differences were found between Aand B groups with respect to PCT (0.218±0.06 vs.
0.212±0.05, p=0.66) and MPV (7.17±0.98 vs. 7.54±1.21fL, p=0.66). In severe OSAS group, MPV and PCT
werenot correlated with AHİ (r=0.37, p=0.801 and r=0.61, p=0.624).
Conclusion: MPV and PCT levels werenot higher in severe OSAS group compared to the control group.
Unlike previous studies, these findings suggest that MPV isnot associated with the severity of OSAS and
OSAS does not directly affect the platelet activity
___
- 1) Young T, Finn L, Peppard PE, et al. Sleep disordered
breathing and mortality: Eighteen-year follow-up of the
Wisconsin sleep cohort. Sleep 2008;31(8):1071-8.
2) Wolk R, Kara T, Somers VK. Sleep-disordered
breathing and cardiovascular disease. Circulation
2003;108(1):9-12. Review.
3) Minoguchi K, Yokoe T, Tazaki T, et al. Silent brain
infarction and platelet activation in obstructive sleep
apnea. Am J Respir Crit Care Med 2007;175(6):612-7.
4) Mehra R, Benjamin EJ, Shahar E, et al. Association of
nocturnal arrhythmias with sleep-disordered breathing:
The Sleep Heart Health Study. Am J Respir Crit Care
Med 2006;173(8):910-6.
5) Marin JM, Carrizo SJ, Vicente E, et al. Long-term
cardiovascular outcomes in men with obstructive sleep
apnoea-hypopnoea with orwithout treatment with
continuous positive airway pressure: An observational
study. Lancet 2005;365(9464):1046-53.
6) Shahar E, Whitney CW, Redline S, et al. Sleepdisordered
breathing and cardiovascular disease. Crosssectional
results of the sleep hearthealth study. Am J
Respir Crit Care Med 2001;163:19-25.
7) Schulz R. The vascular micromilieu in obstructive
sleep apnoea.Eur Respir J 2005;25(5):780-2.
8) Ryan S, Taylor CT, McNicholas WT, Ryan S, Taylor
CT,McNicholas WT. Selective activation of
inflammatory pathways by intermittent hypoxia in
obstructive sleep apnea syndrome.Circulation
2005;112(17):2660-7.
9) Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A,
Tyson K,Chrousos GP. Elevation of plasma cytokines in
disorders of excessive daytime sleepiness: role of sleep
disturbance and obesity. J Clin Endocrinol Metab
1997;82(5):1313-6.
10) Thompson CB, Eaton KA, Princiotta SM, Rushin CA,
Valeri CR. Size dependent platelet subpopulations:
relationship of platelet volume to ultrastructure,
enzymatic activity, and function. Br J Haematol
1982;50(3):509-19.
11)Briggs C. Quality counts: new parameters in blood cell
counting. Int J Lab Hematol 2009;31(3):277-97. Review.
12) Vizioli L, Muscari S, Muscari A, “The relationship of
mean platelet volume with the risk and prognosis of
cardiovascular diseases,” Int J Clin Pract,
2009;63(10):1509-15.
13) Korkmaz L, Korkmaz AA, Akyüz AR, et al.,
Association between mean platelet volume and coronary
artery calcification in patients without overt
cardiovascular disease: an observational study. Anadolu
Kardiyoloji Dergisi, 2012;(12)1: 35–9,.
14) Geiser T, Buck F, Meyer BJ, et al. In vivo platelet
activation is increased during sleep in patients with
obstructive sleep apnea syndrome. Respiration
2002;69(3):229-34.
15) Hui DS, Ko FW, Fok JP, et al. The effects of nasal
continuous positive airway pressure on platelet acti¬vation
in obstructive sleep apnea syndrome. Chest
2004;125(5):1768-75.
16) Erden EŞ, Yengil E, Tuncel E, Bilgiç HK, Demirköse M,
Motor S, Genç S. Investigation of the relationship between
mean platelet volume and obstructive sleep apnea syndrome
J Clin Exp Invest 2013;4(4):492-6.
17) Varol E, Ozturk O, Gonca T, et all. Mean platelet volume
is increased in patients with severe obstructive sleep apnea.
Scand J Clin Lab Invest 2010;70(7):497-502.
18) Kanbay A, Tutar N, Kaya E, et al. Mean platelet volume
in patients with obstructive sleep apnea syn¬drome and its
relationship with cardiovascular diseases. Blood Coagul
Fibrinolysis 2013;24(5):532-6.
19) Nena E, Papanas N, Steiropoulos P, et al. Mean Platelet
Volume and Platelet Distribution Width in non-diabetic
subjects with obstructive sleep apnoea syndrome: new
indices of severity? Platelets 2012;23(6):447-54.
20) Sökücü SN, Özdemir C, Dalar L, Karasulu L, Aydın F,
Altın S. Is Mean Platelet Volume Really a Severity Marker
for Obstructive Sleep Apnea Syndrome without
Comorbidities? Pulm Med. 2014;2014:754839
21) Rahangdale S, Yeh SY, Novack V et all. “The influence
of intermittent hypoxemia on platelet activation in obese
patients with obstructive sleep apnea,” J Clin Sleep Med.
2011;7(2):172-8.